Cumberland Pharmaceuticals Inc. Unrealized Gain (Loss) on Investments
Cumberland Pharmaceuticals Inc. (CPIX) reported Unrealized Gain (Loss) on Investments of -$146.08 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-08.
Financial Statements › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2026-05-08
- Cumberland Pharmaceuticals Inc. unrealized gain (loss) on investments for the quarter ending 2026-03-31 was -$146.08K.
- Cumberland Pharmaceuticals Inc. unrealized gain (loss) on investments for the quarter ending 2025-03-31 was $0.00.
- Cumberland Pharmaceuticals Inc. unrealized gain (loss) on investments for the quarter ending 2021-12-31 was $0.00.
- Cumberland Pharmaceuticals Inc. unrealized gain (loss) on investments for the quarter ending 2021-09-30 was $0.00.
- Cumberland Pharmaceuticals Inc. unrealized gain (loss) on investments for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Cumberland Pharmaceuticals Inc. unrealized gain (loss) on investments for fiscal 2021 was $2.19M.
- Cumberland Pharmaceuticals Inc. unrealized gain (loss) on investments for fiscal 2020 was $0.00.
- Cumberland Pharmaceuticals Inc. unrealized gain (loss) on investments for fiscal 2019 was $0.00.
| Period end | Unrealized Gain (Loss) on Investments 3 month | Unrealized Gain (Loss) on Investments 3 month as first filed | Unrealized Gain (Loss) on Investments 6 month | Unrealized Gain (Loss) on Investments 9 month | Unrealized Gain (Loss) on Investments 12 month |
|---|---|---|---|---|---|
| 2026-03-31 | -$146.08K 10-Q · filed 2026-05-08 | ||||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-08 | ||||
| 2022-12-31 | $0.00 10-K · filed 2023-03-13 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $0.00 derived: sum of 2 quarters · filed 2023-03-13 | $2.19M 10-K · filed 2023-03-13 | ||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $2.19M 10-Q · filed 2021-11-12 | |||
| 2021-06-30 | $2.19M 10-Q · filed 2021-08-13 | ||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $0.00 derived: sum of 2 quarters · filed 2022-03-11 | $0.00 derived: sum of 3 quarters · filed 2022-03-11 | $0.00 10-K · filed 2022-03-11 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $0.00 derived: sum of 2 quarters · filed 2021-11-12 | $0.00 10-Q · filed 2021-11-12 | -$34.30K derived: sum of 4 quarters · filed 2022-03-11 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $0.00 10-Q · filed 2021-08-13 | -$34.30K derived: sum of 3 quarters · filed 2022-03-11 | -$125.80K derived: sum of 4 quarters · filed 2022-03-11 | |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-22 | -$34.30K derived: sum of 2 quarters · filed 2022-03-11 | -$125.80K derived: sum of 3 quarters · filed 2022-03-11 | -$44.19K derived: sum of 4 quarters · filed 2022-03-11 | |
| 2019-12-31 | -$34.30K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | -$125.80K derived: sum of 2 quarters · filed 2022-03-11 | -$44.19K derived: sum of 3 quarters · filed 2022-03-11 | $0.00 10-K · filed 2022-03-11 | |
| 2019-09-30 | -$91.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | -$9.89K derived: sum of 2 quarters · filed 2020-11-13 | $34.30K 10-Q · filed 2020-11-13 | ||
| 2019-06-30 | $81.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $125.80K 10-Q · filed 2020-08-14 | |||
| 2019-03-31 | $44.19K 10-Q · filed 2020-05-22 | ||||
| 2018-09-30 | $13.46K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $88.31K derived: sum of 2 quarters · filed 2019-11-13 | $131.65K 10-Q · filed 2019-11-13 | ||
| 2018-06-30 | $74.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $118.19K 10-Q · filed 2019-08-14 | |||
| 2018-03-31 | $43.34K 10-Q · filed 2019-05-15 | -$43.34K 10-Q · filed 2018-05-09 | |||
| 2017-09-30 | $29.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $52.89K derived: sum of 2 quarters · filed 2018-11-14 | $48.08K 10-Q · filed 2018-11-14 | ||
| 2017-06-30 | $23.51K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $18.71K 10-Q · filed 2018-08-14 | |||
| 2017-03-31 | -$4.81K 10-Q · filed 2018-05-09 | $4.81K 10-Q · filed 2017-05-15 | |||
| 2016-09-30 | $17.93K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $22.56K derived: sum of 2 quarters · filed 2017-11-08 | $69.14K 10-Q · filed 2017-11-08 | ||
| 2016-06-30 | $4.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $51.21K 10-Q · filed 2017-08-09 | |||
| 2016-03-31 | $46.58K 10-Q · filed 2017-05-15 | ||||
| 2015-09-30 | $35.45K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $59.50K derived: sum of 2 quarters · filed 2016-11-03 | $80.32K 10-Q · filed 2016-11-03 | ||
| 2015-06-30 | $24.05K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $44.87K 10-Q · filed 2016-08-05 | |||
| 2015-03-31 | $20.82K 10-Q · filed 2016-05-13 | ||||
| 2014-09-30 | $43.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $3.29K derived: sum of 2 quarters · filed 2015-11-06 | -$138.63K 10-Q · filed 2015-11-06 | ||
| 2014-06-30 | -$40.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$181.95K 10-Q · filed 2015-08-07 | |||
| 2014-03-31 | -$141.92K 10-Q · filed 2015-05-15 | ||||
| 2013-09-30 | -$72.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$124.72K derived: sum of 2 quarters · filed 2014-11-07 | -$135.30K 10-Q · filed 2014-11-07 | ||
| 2013-06-30 | -$51.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | -$62.32K 10-Q · filed 2014-08-08 | |||
| 2013-03-31 | -$10.57K 10-Q · filed 2014-05-12 | ||||
| 2012-09-30 | $64.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $90.49K derived: sum of 2 quarters · filed 2013-11-06 | $99.29K 10-Q · filed 2013-11-06 | ||
| 2012-06-30 | $25.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $34.60K 10-Q · filed 2013-08-09 | |||
| 2012-03-31 | $8.80K 10-Q · filed 2013-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |